Cost-Effectiveness of Tisagenlecleucel in Paediatric Acute Lymphoblastic Leukaemia (pALL) and Adult Diffuse Large B-Cell Lymphoma (DLBCL) in Switzerland

Moradi-Lakeh, M; Yaghoubi, M; Seitz, P; Javanbakht, M; Brock, E

Brock, E (corresponding author), HealthEcon AG, Postfach 1510, CH-4001 Basel, Switzerland.

ADVANCES IN THERAPY, 2021; 38 (6): 3427

Abstract

Introduction The purpose of the present analysis was to explore the cost-effectiveness of tisagenlecleucel in relapsed or refractory (r/r) paediatric ......

Full Text Link